Op-Eds
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Corporate Social Responsibility In Mental Health: The Missing Link in India's Nation Building Strategy
- Changing public health needs and the role of capacity building Institutions in India
- The Invisible Epidemic: Why the World's First Corporate Mental Health Portal Was Born
- Is drug resistance the next big pandemic?
